Search Results - "Azkona, E."

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Epidermal growth factor receptor tyrosine-kinase inhibitor treatment resistance in non-small cell lung cancer: biological basis and therapeutic strategies by Carrera, S., Buque, A., Azkona, E., Aresti, U., Calvo, B., Sancho, A., Arruti, M., Nuño, M., Rubio, I., de Lobera, A. R., Lopez, C., Vivanco, G. L.

    Published in Clinical & translational oncology (01-04-2014)
    “…Lung cancer remains the leading cause of cancer-related death. Non-small cell lung cancer (NSCLC) represents 85 % of all lung cancer cases and it is classified…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    627 - Results of Adjuvant Chemotherapy after Hepatic and/or Lung Metastases Resection of Colorectal Cancer by Damian, E.I. Gutiérrez, Gutiérrez, A. Sancho, Arruti, M., Carrera, S., Rubio, I., Marrodan, I., Muñoz, A., Azkona, E., Buque, A., Lopez-Vivanco, G.

    Published in Annals of oncology (01-09-2012)
    “…Adjuvant chemotherapy following metastases resection of colorectal cancer is recommended although the benefit has not been clearly demonstrated in clinical…”
    Get full text
    Journal Article
  7. 7

    Preoperative chemoradiotherapy with capecitabine and oxaliplatin in patients with locally advanced rectal cancer by Marrodan, I., Azkona, E., Carrera, S., Aresti, U., Calvo, B., Buque, A., Sancho, A., Ruiz de Lobera, A., Munoz Llarena, A., Lopez-Vivanco, G.

    Published in Journal of clinical oncology (01-02-2011)
    “…Abstract only 548 Background: Locally advanced rectal carcinoma is associated with high rate of abdomino-perineal amputation. We analyzed a cohort of patients…”
    Get full text
    Journal Article
  8. 8

    Percutaneous transhepatic biliary drainage (PTBD) and endoscopic retrograde cholangiopancreatography (ERCP) for malignant obstructive jaundice (OJ) in advanced digestive cancers by Iruarrizaga, E., Azkona, E., Martinez, M., Iza, E., Lopez-Vivanco, G., Munoz Llarena, A., Ferreiro, J., Ballesteros, D., Fernandez, R., Rubio, I.

    Published in Journal of clinical oncology (01-02-2011)
    “…Abstract only 348 Background: OJ is a relatively frequent complication in patients with advanced malignancies that usually causes refractory symptoms and can…”
    Get full text
    Journal Article
  9. 9

    Induction cisplatin, paclitaxel, and 5FU (PTF) before definitive local therapy for locally advanced esophageal squamous cell carcinoma (SCC) by Fernandez, R., Lopez de Argumedo, G., Fuente, N., Ferreiro, J., Martinez, M., Azkona, E., Gutierrez, E., Iza, E., Casas, R., Mane, J.

    Published in Journal of clinical oncology (01-02-2011)
    “…Abstract only 115 Background: Induction chemotherapy for locally advanced oesophageal SCC is controversial. Triple combination is under study with promising…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12